Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatmentFootnote

Peer review under responsibility of Arab Association of Urology.

References

• E.A.JanniniM.MaggiA.LenziEvaluation of premature ejaculationJ Sex Med8Suppl. 42011328334
   Google Scholar
• Rosen R, Porst H, Montorsi F. The Premature Ejaculation Prevalence and Attitudes (PEPA) Survey: a Multi-National Survey [Abstract]. Proceedings of the 11th World Congress of the International Society of Sexual and Impotence Research 2004, 17–21 October 2004.
   Google Scholar
• P.SanttilaP.JernL.WestbergH.WalumC.T.PedersenE.Erikssonet alThe dopamine transporter gene (DAT1) polymorphism is associated with premature ejaculationJ Sex Med7201015381546
   PubMed Web of Science ®Google Scholar
• P.K.JanssenS.C.BakkerJ.RéthelyiA.H.ZwindermanD.J.TouwB.Olivieret alSerotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculationJ Sex Med62009276284
   PubMed Web of Science ®Google Scholar
• P.JernL.WestbergA.JohanssonL.JonssonJ.CoranderN.K.Sandnabbaet alAre single nucleotide polymorphisms in the oxytocin and vasopressin 1A/1B receptor genes likely candidates for variation in ejaculatory function?BJU Int1102012 E1173-80
   Web of Science ®Google Scholar
• K.HatzimouratidisE.AmarI.EardleyF.GiulianoD.HatzichristouF.Montorsiet alGuidelines on male sexual dysfunction: erectile dysfunction and premature ejaculationEur Urol572010804814
   PubMed Web of Science ®Google Scholar
• M.ArafaR.ShamloulDevelopment and evaluation of the arabic index of premature ejaculation (AIPE)J Sex Med4200717501756
   Web of Science ®Google Scholar
• D.L.PatrickF.GiulianoK.F.HoD.D.GagnonP.McNultyM.RothmanThe premature ejaculation profile. Validation of self-reported outcome measures for research and practiceBJU Int1032009358364
   PubMed Web of Science ®Google Scholar
• T.SymondsM.A.PerelmanS.AlthofF.GiulianoM.MartinK.Mayet alDevelopment and validation of a premature ejaculation diagnostic toolEur Urol522007565573
   PubMed Web of Science ®Google Scholar
• M.D.WaldingerTowards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodologyInt J Impot Res152003309313
   PubMed Web of Science ®Google Scholar
• A.M.IsidoriC.PozzaK.EspositoD.GiuglianoS.MoranoL.Vignozziet alDevelopment and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunctionJ Sex Med7201011391146
   PubMed Web of Science ®Google Scholar
• S.E.AlthofC.H.AbdoJ.DeanG.HackettM.McCabeC.G.McMahonet alInternational society for sexual medicine. International society for sexual medicine’s guidelines for the diagnosis and treatment of premature ejaculationJ Sex Med7201029472969
   PubMed Web of Science ®Google Scholar
• C.YangK.TangB.WangClinical value of serum 5-HT level in diagnosis and treatment of premature ejaculationUrol Int902013214218
   Web of Science ®Google Scholar
• F.GiulianoD.L.RowlandStandard operating procedures for neurophysiologic assessment of male sexual dysfunctionJ Sex Med10201312051211
   Web of Science ®Google Scholar
• A.MoralesEvolving therapeutic strategies for premature ejaculation: The search for on-demand treatment – topical versus systemicCan Urol Assoc J62012380385
   Web of Science ®Google Scholar
• M.G.WyllieW.J.HellstromThe link between penile hypersensitivity and premature ejaculationBJU Int1072011452457
   PubMed Web of Science ®Google Scholar
• M.G.WyllieJ.A.PowellThe role of local anaesthetics in premature ejaculationBJU Int1102012 E943-8
   Web of Science ®Google Scholar
• W.W.DinsmoreM.G.WylliePSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled studyBJU Int1032009940949
   PubMed Web of Science ®Google Scholar
• C.CarsonM.WyllieImproved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled studyJ Sex Med7201031793189
   PubMed Web of Science ®Google Scholar
• D.Bar-OrK.M.SalottoloA.OrlandoJ.V.WinklerTramadol ODT study group. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minEur Urol612012736743
   PubMed Web of Science ®Google Scholar
• M.C.FrinkH.H.HenniesW.EnglbergerM.HaurandB.WilffertInfluence of tramadol on neurotransmitter systems of the rat brainArzneimittelforschung46199610291036
   PubMed Web of Science ®Google Scholar
• M.R.SafarinejadS.Y.HosseiniSafety and efficacy of tramadol in the treatment of premature ejaculation a double-blind, placebo-controlled, fixed-dose, randomized studyJ Clin Psychopharmacol2620062731
   PubMed Web of Science ®Google Scholar
• B.I.EassaM.A.El-ShazlySafety and efficacy of tramadol hydrochloride on treatment of premature ejaculationAsian J Androl152013138142
   PubMed Web of Science ®Google Scholar
• B.L.WongS.MaldeThe use of tramadol ‘on-demand’ for premature ejaculation: a systematic reviewUrology81201398103
   Web of Science ®Google Scholar
• T.WuX.YueX.DuanD.LuoY.ChengY.Tianet alEfficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysisUrology802012618624
   PubMed Web of Science ®Google Scholar
• M.CossmannC.KohnenR.LangfordC.McCartneyTolerance and safety of tramadol use. Results of international studies and data from drug surveillanceDrugs53Suppl. 219975062
   Google Scholar
• G.X.ZhangL.P.YuW.J.BaiX.F.WangSelective resection of dorsal nerves of penis for premature ejaculationInt J Androl352012873879
   Google Scholar
• E.E.RhameK.A.LeveyC.G.GhariboSuccessful treatment of refractory pudendal neuralgia with pulsed radiofrequencyPain Phys122009633638
   PubMed Web of Science ®Google Scholar
• J.David PrologoL.L.SnyderE.CherulloM.PassalacquaA.PirastehD.Cornet alguided cryoablation of the dorsal penile nerve for treatment of symptomatic premature ejaculationJ Vasc Interv Radiol242013214219
   Web of Science ®Google Scholar
• O.ShaeerK.ShaeerThe global online sexuality survey (GOSS.): erectile dysfunction among arabic-speaking internet users in the Middle EastJ Sex Med9201121522163
   Google Scholar
• O.ShaeerK.ShaeerThe global online sexuality survey (GOSS). The United States of America in 2011. Chapter I. Erectile dysfunction among English-speakersJ Sex Med9201230183027
   PubMed Web of Science ®Google Scholar
• O.ShaeerThe global online sexuality survey (GOSS). The United States of America in 2011 chapter II. Phosphodiesterase inhibitors utilization among English speakersJ Sex Med102013532540
   PubMed Web of Science ®Google Scholar
• S.GlinaI.D.SharlipW.J.G.HellstromModifying risk factors to prevent and treat erectile dysfunctionJ Sex Med102013115119
   PubMed Web of Science ®Google Scholar
• I.AhmedA.El-SakkaErectile dysfunction in Arab countries. Part I prevalence and correlatesArab J Urol10201297103
   Google Scholar
• W.GuoC.LiaoY.ZouF.LiT.LiQ.Zhouet alErectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studiesJ Sex Med7201028052816
   PubMed Web of Science ®Google Scholar
• A.B.AraujoT.G.TravisonP.GanzG.R.ChiuV.KupelianR.C.Rosenet alErectile dysfunction and mortalityJ Sex Med6200924452454
   PubMed Web of Science ®Google Scholar
• J.M.HotalingT.J.WalshL.C.MacleodS.HeckbertG.PocobelliH.Wessellset alErectile dysfunction is not independently associated with cardiovascular death. Data from the vitamins and lifestyle (VITAL) studyJ Sex Med9201221042110
   Web of Science ®Google Scholar
• E.BanksG.JoshyW.P.AbhayaratnaL.KritharidesP.S.MacdonaldR.J.Kordaet alErectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort studyPlos Med102013e1001372
   PubMed Web of Science ®Google Scholar
• T.YamadaK.HaraH.UmematsuR.SuzukiT.KadowakiErectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studiesPlos One72012e43673
   PubMed Web of Science ®Google Scholar
• J.Y.DongY.H.ZhangL.Q.QinErectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studiesJ Am Coll Cardiol58201113781385
   PubMed Web of Science ®Google Scholar
• H.M.GhanemA.SaloniaA.S.Martin-MoralesPhysical examination and laboratory testing for men with erectile dysfunctionJ Sex Med102013108110
   PubMed Web of Science ®Google Scholar
• R.C.RosenA.RileyG.WagnerI.H.OsterlohJ.KirkpatrickA.MishraThe international index of erectile dysfunction (IIEF), a multidimensional scale for assessment of erectile dysfunctionUrology491997822830
   PubMed Web of Science ®Google Scholar
• D.HatzichristouR.C.RosenL.R.DerogatisW.Y.LowE.J.H.MeulemanR.Sadovskyet alRecommendations for the clinical evaluation of men and women with sexual dysfunctionJ Sex Med72010337348
   PubMed Web of Science ®Google Scholar
• J.BuvatHyperprolactinemia and sexual function in men: a short reviewInt J Impot Res152003373377
   PubMed Web of Science ®Google Scholar
• S.C.SikkaW.J.G.HellstromG.BrockA.M.MoralesStandardization of vascular assessment of erectile dysfunctionJ Sex Med102013120129
   PubMed Web of Science ®Google Scholar
• A.J.BellaA.SenerK.FoellG.B.BrockNonpalpable scarring of the penile septum as a cause of erectile dysfunction: an atypical form of Peyronie’s diseaseJ Sex Med42007226230
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaA.M.MorsyB.I.FagihSeverity of erectile dysfunction could predict left ventricular diastolic dysfunction in patients without overt cardiac complaintJ Sex Med8201125902597
   PubMed Web of Science ®Google Scholar
• C.N.McMahonC.J.SmithR.ShabsighTreating erectile dysfunction when PDE5 inhibitors failBMJ3322006589592
   PubMed Web of Science ®Google Scholar
• H.SonK.ParkS.W.KimJ.S.PaickReasons for discontinuation of sildenafil citrate after successful restoration of erectile functionAsian J Androl62004117120
   PubMed Web of Science ®Google Scholar
• C.G.McMahonComparison, efficacy, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunctionJ Sex Med22005415425
   PubMed Web of Science ®Google Scholar
• D.A.PaduchA.BolyakovP.K.PolzerS.D.WattsEffects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studiesBJU Int1112013334343
   Web of Science ®Google Scholar
• A.D.SeftelJ.de la RosetteJ.BirtV.PorterV.ZarotskyL.ViktrupCoexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological dataInt J Clin Pract6720133245
   PubMed Web of Science ®Google Scholar
• G.A.BroderickG.B.BrockC.G.RoehrbornS.D.WattsA.Elion-MboussaL.ViktrupEffects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunctionUrology75201014521459
   PubMed Web of Science ®Google Scholar
• C.G.RoehrbornJ.C.KaminetskyS.M.AuerbachR.M.MontelongoA.Elion-MboussaL.ViktrupChanges in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatmentBJU Int1052009502507
   Web of Science ®Google Scholar
• M.OelkeF.GiulianoV.MironeL.XuD.CoxL.ViktrupMonotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trialEur Urol612012917925
   PubMed Web of Science ®Google Scholar
• R.B.EgerdieS.AuerbachC.G.RoehrbornP.CostaM.S.GarzaA.L.Esleret alTadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind studyJ Sex Med92012271281
   PubMed Web of Science ®Google Scholar
• L.X.De YoungT.DomesK.LimJ.CarsonG.B.BrockEndothelial rehabilitation. The impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic ratsEur Urol542008213220
   PubMed Web of Science ®Google Scholar
• A.AversaC.VitaleM.VolterraniA.FabbriG.SperaM.Finiet alChronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetesDiabet Med2520083744
   PubMed Web of Science ®Google Scholar
• C.J.WangF.S.WangK.D.YangL.H.WengC.C.HsuC.S.Huanget alShock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbitsJ Orthop Res212003984989
   PubMed Web of Science ®Google Scholar
• T.NishidaH.ShimokawaK.OiH.TatewakiT.UwatokuK.Abeet alExtracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivoCirculation110200430553061
   PubMed Web of Science ®Google Scholar
• P.YangT.GuoW.WangY.Z.PengY.WangP.Zhouet alRandomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart diseaseHeart Vessels282013284291
   PubMed Web of Science ®Google Scholar
• Y.VardiB.AppelG.JacobO.MassarwiI.GruenwaldCan low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunctionEur Urol582010243248
   PubMed Web of Science ®Google Scholar
• Y.VardiB.AppelA.KilchevskyI.GruenwaldDoes low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled studyJ Urol187201217691775
   PubMed Web of Science ®Google Scholar
• I.GruenwaldB.AppelN.D.KitreyY.VardiShockwave treatment of erectile dysfunctionTher Adv Urol520139599
   PubMedGoogle Scholar
• J.H.RogersK.J.Rocha-SinghEndovascular therapy for vasculogenic erectile dysfunctionCurr Treat Options Cardiovasc Med142012193202
   Google Scholar
• M.A.KutcherThe ‘Final Voyage’ of the endeavor stentJACC Cardiovasc Interv62013513515
   Web of Science ®Google Scholar
• J.H.RogersH.KarimiJ.KaoD.LinkJ.JavidanD.S.Yamasakiet alInternal pudendal artery stenoses and erectile dysfunction: correlation with angiographic coronary artery diseaseCatheter Cardiovasc Interv762010882887
   PubMed Web of Science ®Google Scholar
• J.H.RogersI.GoldsteinD.E.KandzariT.S.KöhlerC.T.StinisP.J.Wagneret alZotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitorsJ Am Coll Cardiol60201226182627
   PubMed Web of Science ®Google Scholar